Join the waitlist.

Wolverine is a science-forward peptide subscription platform launching after PCAC review in 2026. We're building a qualified list of US patients ready to subscribe the moment the clinical platform opens.

We collect your email and US state only. No phone number. No medical history. No peptide interest questions. Data minimisation is a design constraint, not an afterthought.